Literature DB >> 17720863

Eugenol inhibits K+ currents in trigeminal ganglion neurons.

H Y Li1, C-K Park, S J Jung, S-Y Choi, S J Lee, K Park, J S Kim, S B Oh.   

Abstract

UNLABELLED: Eugenol, a natural capsaicin congener, is widely used in dentistry. Eugenol inhibits voltage-activated Na(+) and Ca(2+) channels in a transient receptor potential vanilloid 1 (TRPV1)-independent manner. We hypothesized that eugenol also inhibits voltage-gated K(+) currents, and investigated this in rat trigeminal ganglion neurons and in a heterologous system using whole-cell patch clamping. Eugenol inhibited voltage-gated K(+) currents, and the inhibitory effects of eugenol were observed in both capsaicin-sensitive and capsaicin-insensitive neurons. Pre-treatment with capsazepine, a well-known antagonist of TRPV1, failed to block the inhibitory effects of eugenol on K(+) currents, suggesting no involvement of TRPV1. Eugenol inhibited human Kv1.5 currents stably expressed in Ltk(-) cells, where TRPV1 is not endogenously expressed. We conclude that eugenol inhibits voltage-gated K(+) currents in a TRPV1-independent manner. The inhibition of voltage-gated K(+) currents is likely to contribute to the irritable action of eugenol. ABBREVIATIONS: human Kv1.5 channel, hKv1.5; transient receptor potential vanilloid 1, TRPV1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720863     DOI: 10.1177/154405910708600918

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  13 in total

Review 1.  Anaesthesia of farmed fish: implications for welfare.

Authors:  Inger Hilde Zahl; Ole Samuelsen; Anders Kiessling
Journal:  Fish Physiol Biochem       Date:  2011-12-09       Impact factor: 2.794

2.  Eugenol Inhibits ATP-induced P2X Currents in Trigeminal Ganglion Neurons.

Authors:  Hai Ying Li; Byung Ky Lee; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Korean J Physiol Pharmacol       Date:  2008-12-31       Impact factor: 2.016

Review 3.  Recent development in antihyperalgesic effect of phytochemicals: anti-inflammatory and neuro-modulatory actions.

Authors:  Ajeet Kumar Singh; Sanjay Kumar; Manjula Vinayak
Journal:  Inflamm Res       Date:  2018-05-16       Impact factor: 4.575

Review 4.  Recent advances in basic research on the trigeminal ganglion.

Authors:  Tetsuya Goto; Seog Bae Oh; Mamoru Takeda; Masamichi Shinoda; Tadasu Sato; Kaori K Gunjikake; Koichi Iwata
Journal:  J Physiol Sci       Date:  2016-03-29       Impact factor: 2.781

5.  Anesthesia induces stress in Atlantic salmon (Salmo salar), Atlantic cod (Gadus morhua) and Atlantic halibut (Hippoglossus hippoglossus).

Authors:  Inger Hilde Zahl; Anders Kiessling; Ole Bent Samuelsen; Rolf Erik Olsen
Journal:  Fish Physiol Biochem       Date:  2009-08-13       Impact factor: 2.794

6.  Effects of eugenol on respiratory burst generation in newborn rat brainstem-spinal cord preparations.

Authors:  Sayumi Kotani; Saki Irie; Masahiko Izumizaki; Hiroshi Onimaru
Journal:  Pflugers Arch       Date:  2017-09-29       Impact factor: 3.657

7.  Fractionation of a herbal antidiarrheal medicine reveals eugenol as an inhibitor of Ca2+-Activated Cl- channel TMEM16A.

Authors:  Zhen Yao; Wan Namkung; Eun A Ko; Jinhong Park; Lukmanee Tradtrantip; A S Verkman
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  TRP Channels Involved in Spontaneous L-Glutamate Release Enhancement in the Adult Rat Spinal Substantia Gelatinosa.

Authors:  Eiichi Kumamoto; Tsugumi Fujita; Chang-Yu Jiang
Journal:  Cells       Date:  2014-04-29       Impact factor: 6.600

9.  Eugenol inhibits the GABAA current in trigeminal ganglion neurons.

Authors:  Sang Hoon Lee; Jee Youn Moon; Sung Jun Jung; Jin Gu Kang; Seung Pyo Choi; Jun Ho Jang
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

Review 10.  The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?

Authors:  Yani Liu; Zongtao Liu; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2020-12-09       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.